Accretion Pharmaceuticals Schedules Board Meeting to Consider Half-Year Results
Accretion Pharmaceuticals Ltd 路 Intimation 路 31 Oct 2026, 5:30 am
Accretion Pharmaceuticals Schedules Board Meeting to Consider Half-Year Results Accretion Pharmaceuticals Limited has notified the stock exchanges that a meeting of its Board of Directors is scheduled for 31st Oct'26. The board will inter-alia consider and approve the company's unaudited financial results for the half-year ended Sep'26.
More announcements from Accretion Pharmaceuticals Ltd
- Accretion Pharmaceuticals Limited has informed the Exchange about General Updates 路 16 Nov 2026
- Accretion Pharmaceuticals Limited has informed the Exchange about Investor Presentation 路 03 Nov 2026
- Accretion Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 02 Nov 2026
- Accretion Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 31, 2026, titled "Company Reports 25.83% Revenue Growth and 72.63% PAT Growth in H1 FY27 and Strong EBITDA Growth of 72.28%; EBITDA Margin Improves to 22.48%". 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has submitted to the Exchange, the unaudited financial results for the half year ended September 30, 2026. 路 31 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy of Srutinizers report. 路 12 Oct 2026
- Accretion Pharmaceuticals Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company. 路 11 Oct 2026
